GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

atibuclimab   Click here for help

GtoPdb Ligand ID: 11326

Synonyms: IC14
Immunopharmacology Ligand
Compound class: Antibody
Comment: Atibuclimab (IC14) is a monoclonal antibody against CD14 [1]. It was developed by ICOS Corporation (acquired by Eli Lilly) and was progressed as a potential COVID-19 therapeutic by Implicit Bioscience.
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
11865 atibuclimab
Synonyms Click here for help
IC14
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 155
Other databases
GtoPdb PubChem SID 434321761
Search PubMed clinical trials atibuclimab
Search PubMed titles atibuclimab
Search PubMed titles/abstracts atibuclimab